| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Shen M, Piser TM, Seybold... |
Cannabinoid receptor agonists inhibit glutamatergic synaptic transmiss... |
J Neurosci |
1996 |
| Smith FL, Cichewicz D, Ma... |
The enhancement of morphine antinociception in mice by delta9-tetrahyd... |
Pharmacol Biochem Be... |
1998 |
| Gessa GL, Casu MA, Carta ... |
Cannabinoids decrease acetylcholine release in the medial-prefrontal c... |
Eur J Pharmacol |
1998 |
| Gessa GL, Casu MA, Carta ... |
Cannabinoids decrease acetylcholine release in the medial-prefrontal c... |
Eur J Pharmacol |
1998 |
| Shen M, Thayer SA |
Cannabinoid receptor agonists protect cultured rat hippocampal neurons... |
Mol Pharmacol |
1998 |
| Meschler JP, Howlett AC |
Thujone exhibits low affinity for cannabinoid receptors but fails to e... |
Pharmacol Biochem Be... |
1999 |
| Nagayama T, Sinor AD, Sim... |
Cannabinoids and neuroprotection in global and focal cerebral ischemia... |
J Neurosci |
1999 |
| Sinor AD, Irvin SM, Green... |
Endocannabinoids protect cerebral cortical neurons from in vitro ische... |
Neurosci Lett |
2000 |
| Galve-Roperh I, Sa¡nchez ... |
Anti-tumoral action of cannabinoids: involvement of sustained ceramide... |
Nat Med |
2000 |
| van der Stelt M, Veldhuis... |
Neuroprotection by Delta9-tetrahydrocannabinol, the main active compou... |
J Neurosci |
2001 |
| Mechoulam R, Panikashvili... |
Cannabinoids and brain injury: therapeutic implications |
Trends Mol Med |
2002 |
| Zalish M, Lavie V |
Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and s... |
Vision Res |
2003 |
| Brotchie JM |
CB1 cannabinoid receptor signalling in Parkinson's disease |
Curr Opin Pharmacol |
2003 |
| Croxford JL |
Therapeutic potential of cannabinoids in CNS disease |
CNS Drugs |
2003 |
| Veldhuis WB, van der Stel... |
Neuroprotection by the endogenous cannabinoid anandamide and arvanil a... |
J Neurosci |
2003 |
| Iversen L |
Cannabis and the brain |
Brain |
2003 |
| Darlington CL |
Dexanabinol: A novel cannabinoid with neuroprotective properties |
IDrugs |
2003 |
| Leggett JD, Aspley S, Bec... |
Oleamide is a selective endogenous agonist of rat and human CB1 cannab... |
Br J Pharmacol |
2004 |
| Braida D, Iosue S, Pegori... |
Delta-9-Tetrahydrocannabinol-induced conditioned place preference and ... |
European Journal of ... |
2004 |
| Ramirez BG, Blazquez C, G... |
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprot... |
J Neurosci |
2005 |
| Gobbi G, Bambico FR, Mang... |
Antidepressant-like activity and modulation of brain monoaminergic tra... |
pnas |
2005 |
| Kim K, Moore DH, Makriyan... |
AM1241, a cannabinoid CB(2) receptor selective compound, delays diseas... |
Eur J Pharmacol |
2006 |
| Braida D, Limonta V, Pego... |
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa... |
Psychopharmacology (... |
2007 |
| Bambico FR, Katz N, Debon... |
Cannabinoids elicit antidepressant-like behavior and activate serotone... |
J Neurosci |
2007 |
| Senn R, Keren O, Hefetz A... |
Long-term cognitive deficits induced by a single, extremely low dose o... |
Pharmacol Biochem Be... |
2008 |
| Reich CG, Mohammadi MH, A... |
Endocannabinoid modulation of fear responses: learning and state-depen... |
J Psychopharmacol |
2008 |
| Izzo AA, Borrelli F, Capa... |
Non-psychotropic plant cannabinoids: new therapeutic opportunities fro... |
Trends Pharmacol Sci |
2009 |
| Atwood BK, Huffman J, Str... |
JWH018, a common constituent of 'Spice' herbal blends, is a potent and... |
Br J Pharmacol |
2010 |
| Hegde VL, Nagarkatti M, N... |
Cannabinoid receptor activation leads to massive mobilization of myelo... |
Eur J Immunol |
2010 |
| Every-Palmer S |
Synthetic cannabinoid JWH-018 and psychosis: An explorative study |
Drug Alcohol Depend |
2011 |
| Zuba D, Byrska B, Maciow ... |
Comparison of 'herbal highs' composition |
Anal Bioanal Chem |
2011 |
| Uchiyama N, Kikura-Hanaji... |
Identification of a Novel Cannabimimetic Phenylacetylindole, Cannabipi... |
Chem Pharm Bull (Tok... |
2011 |
| Papanti D, Schifano F, Bo... |
Spiceophrenia: a systematic overview of spice-related psychopathologic... |
Hum Psychopharmacol |
2013 |
| Spaderna M, Addy PH, D'So... |
Spicing things up: synthetic cannabinoids |
Psychopharmacology (... |
2013 |
| Tai S, Fantegrossi WE |
Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Po... |
Curr Addict Rep |
2014 |
| Marshell R, Kearney-Ramos... |
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phyt... |
Pharmacol Biochem Be... |
2014 |
| Schifano F, Orsolini L, D... |
Novel psychoactive substances of interest for psychiatry |
World Psychiatry |
2015 |
| Rose DZ, Guerrero WR, Mok... |
Hemorrhagic stroke following use of the synthetic marijuana spice |
Neurology |
2015 |
| Palamar JJ, Su MK, Hoffma... |
Characteristics of novel psychoactive substance exposures reported to ... |
Am J Drug Alcohol Ab... |
2015 |
| Angerer V, Franz F, Schwa... |
Reply to 'Sudden Cardiac Death Following Use of the Synthetic Cannabin... |
J Anal Toxicol |
2016 |
| Shanks KG, Behonick GS |
Death after Use of the Synthetic Cannabinoid 5F-AMB |
Forensic Science Int... |
2016 |
| Newman M, Denton G, Walke... |
The experience of using synthetic cannabinoids: A qualitative analysis... |
European Psychiatry |
2016 |
| Frinculescu A, Lyall CL, ... |
Variation in commercial smoking mixtures containing third-generation s... |
Drug Test Anal |
2016 |
| Palamar JJ, Acosta P, She... |
Self-reported use of novel psychoactive substances among attendees of ... |
Am J Drug Alcohol Ab... |
2016 |
| Meyyappan C, Ford L, Vale... |
Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist |
Clin Toxicol (Phila) |
2016 |
| Seywright A, Torrance HJ,... |
Analysis and clinical findings of cases positive for the novel synthet... |
Clin Toxicol (Phila) |
2016 |
| Järbe TU, Raghav JG |
Tripping with Synthetic Cannabinoids (Spice): Anecdotal and Experiment... |
Curr Top Behav Neuro... |
2016 |
| Haden M, Archer JR, Darga... |
MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated Wi... |
Subst Use Misuse |
2016 |
| Mathai D, Gordon M, Muchm... |
Paradoxical increase in synthetic cannabinoid emergency-related presen... |
Bull Menninger Clin |
2016 |
| Adams AJ, Banister SD, Ir... |
Zombie Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in Ne... |
N Engl J Med |
2017 |
| Seither J, Reidy L |
Confirmation of Carfentanil, U-47700 and Other Synthetic Opioids in a ... |
J Anal Toxicol |
2017 |
| Maeda H, Kikura-Hanajiri ... |
AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema |
Clin Toxicol (Phila) |
2017 |
| Malyshevskaya O, Aritake ... |
Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce sei... |
Sci Rep |
2017 |
| Coopman V, Cordonnier J |
'Spice-like' herbal incense laced with the synthetic opioid U-47700 |
Toxicologie Analytiq... |
2018 |
